Please login to the form below
DeepMind
This page shows the latest DeepMind news and features for those working in and with pharma, biotech and healthcare.
Google’s DeepMind opens ‘breakthrough’ protein database to the world
In addition to the human proteome, DeepMind is opening access to the proteomes of 20 other biologically significant organisms – totalling over 350, 000 protein structures overall. ... Prior to DeepMind’s breakthrough, researchers used traditional
Latest news
-
Google’s DeepMind AI outperforms doctors on breast cancer screening
That’s a remarkable finding, according to the researchers behind the study from Google Health’s UK-based DeepMind unit – acquired by the tech giant in 2014 – and Imperial College London.
-
Nerve centre gives Novartis edge in clinical trials
When Google was buying DeepMind…we asked ourselves what we were doing in this field?”.
-
Google boosts healthcare business with new hire
Its portfolio also includes AI-based diagnostics and decision-support system DeepMind, which recently demonstrated its accuracy in diagnosing and recommending patients for treatment in more than 50 sight-threatening diseases.
-
Medical AI gets £50m boost and five new centres in UK
some big names in the sector like DeepMind, SwiftKey and Babylon, as well as a large number of emerging start-ups.
-
Safety first: AI adoption in the healthcare sector
DeepMind worked with the Royal Free to develop an app that Royal Free then deployed to assist diagnosis of acute kidney injury (AKI). ... As part of the development, Royal Free had provided DeepMind with the personal data of around 1.6 million patients.
More from news
Approximately 5 fully matching, plus 8 partially matching documents found.
Latest Intelligence
-
How AI is finally helping rare diseases gain more than just attention
DeepMind’s recent success with its AlphaFold AI is a great example of using AI to solve long- studied scientific challenges; the company backed by Google’s owner Alphabet has in
More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.
Latest from PMHub
-
Can Artificial Intelligence Solve the Healthcare Crisis?
In addition, data protection is of paramount importance. In 2017 the Royal Free Hospital, UK, failed to adequately comply with the Data Protection Act when it supplied Google’s DeepMind with
-
Artificial Intelligence: the new healthcare algorithm
Even Google with their DeepMind Health AI technology, have entered into the first NHS research project investigating how machine learning can help analyse ophthalmic scans, leading to earlier detection and intervention
More from PMHub
Approximately 0 fully matching, plus 2 partially matching documents found.
Subscribe to our email news alerts
-
Senior Medical Writer
- Highly competitive salary
- Early Access Program - Regulatory Affairs (EAP-RA)
- Highly competitive salary
-
Omnichannel Account Director
- £55,000 - £65,000 yearly
- Strategy Director - Healthcare Advertising
- Highly competitive salary
- Associate Director - Global Healthcare Consulting
- Highly competitive salary
-
Pharmacovigilance Project Lead
- Highly competitive salary
-
Pharmacovigilance Manager
- Highly competitive salary
-
Technical Sales Representative
- Highly competitive salary
- Roche and Eli Lilly to collaborate on Alzheimer’s disease blood test
- MHRA to introduce new UK clinical trials framework
- Novo Nordisk suspended from ABPI over ‘serious’ code of practice breaches
- 2023 PM Society Awards – winners announced
- Pfizer pays Royalty Pharma $475m following US approval of migraine nasal spray
- Pfizer and Astellas’ Xtandi shows promise in phase 3 prostate cancer study
- AstraZeneca/MSD’s Lynparza combination approved in UK for prostate cancer
- WHO report highlights impact of COVID-19 pandemic on non-communicable diseases
- Critical success factors and the increasing value of rare disease clinical trials
- Quantum Computing, Artificial Intelligence, & Machine Learning for Drug Discovery
- Novo Nordisk and Dewpoint partner on insulin resistance drug candidates
- AbbVie’s Parkinson’s disease therapy application rejected by FDA
- Team ITG appoints Gerhard Arnhofer as head of customer strategy for life sciences division
- Locus Biosciences announces first patient treated in urinary tract infection trial
- Pfizer pays Royalty Pharma $475m following US approval of migraine nasal spray
- Biogen and Eisai’s Alzheimer’s drug to be covered by US Veterans Health Administration
- VR/AR Applications for Training and Healthcare
PMHub
BOLDSCIENCE
We know what it takes to create brands, to start new conversations, to simply communicate complex science, to change lives…...
Latest intelligence
- Rare diseases: not so rare after all
- The brave new world addressing rare diseases – a way ahead to better and more inclusive treatment...
- Webinar: Evolving Patient Journeys - How to generate deeper insights in a changing healthcare landscape
- Register now for part one in a series, Evolving Patient Journeys, in which our experts look at the main ways in which the patient journey has evolved in recent years....
- DIGITAL EXPERIENCES: LEARNINGS FROM OUTSIDE PHARMA
- It’s long been the case that pharma lags behind other industries when it comes to digital adoption and engagement. So, what can we learn from these other industries, and how...
